These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3001680)

  • 1. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma-CEA, and biochemical receptor status.
    Böcker W; Schweikhart G; Pollow K; Kreienberg R; Klaubert A; Schröder S; Mitze M; Bahnsen J; Stegner HE
    Pathol Res Pract; 1985 Nov; 180(5):490-7. PubMed ID: 3001680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
    Sironi M; Cantaboni A
    Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
    [No Abstract]   [Full Text] [Related]  

  • 3. CEA positivity in sera and breast tumor tissues obtained from the same patients.
    von Kleist S; Wittekind C; Sandritter W; Gropp H
    Pathol Res Pract; 1982; 173(4):390-401. PubMed ID: 6289290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dilutional immunoperoxidase study of proliferative ductal lesions and carcinomata of the breast.
    Wells S; Hasleton PS
    Histopathology; 1981 Sep; 5(5):517-26. PubMed ID: 6269985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma of the breast. An analysis of proportions of intraductal and invasive components.
    Matsukuma A; Enjoji M; Toyoshima S
    Pathol Res Pract; 1991 Jan; 187(1):62-7. PubMed ID: 1851298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and the expression of tissue-carcinoembryonic antigen in grade III carcinoma of the breast.
    van Dam PA; Keersmaeckers G; Van Bockstaele DR; Uyttenbroeck FL
    Eur J Obstet Gynecol Reprod Biol; 1991 Jan; 38(1):59-62. PubMed ID: 1846341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen (CEA) in explants of human breast cancer: comparison of immunohistochemical detection and release during short-term culture.
    Miller WR; Sturgeon CM; Walker RA
    Br J Cancer; 1983 Mar; 47(3):429-32. PubMed ID: 6299320
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
    Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
    Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parameters.
    Duffy MJ; O'Connell M; O'Sullivan F; McKenna B; Allen MA; McDonnell L
    Cancer; 1983 Jan; 51(1):121-3. PubMed ID: 6295590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G; Altenaehr E
    Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status.
    Böcker W; Klaubert A; Bahnsen J; Schweikhart G; Pollow K; Mitze M; Kreienberg R; Beck T; Stegner HE
    Virchows Arch A Pathol Anat Histopathol; 1984; 403(2):149-61. PubMed ID: 6202056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-histochemical localization of tissue polypeptide antigen (TPA) and carcino-embryonic antigen (CEA) in breast cancer. A comparative study.
    Björklund V; Björklund B; Wittekind C; von Kleist S
    Acta Pathol Microbiol Immunol Scand A; 1982 Nov; 90(6):471-6. PubMed ID: 6187181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications.
    Kuhajda FP; Offutt LE; Mendelsohn G
    Cancer; 1983 Oct; 52(7):1257-64. PubMed ID: 6192897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.
    Lundy J; Thor A; Maenza R; Schlom J; Forouhar F; Testa M; Kufe D
    Breast Cancer Res Treat; 1985; 5(3):269-76. PubMed ID: 2992647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors.
    Pignatelli M; Cardillo MR; Hanby A; Stamp GW
    Hum Pathol; 1992 Oct; 23(10):1159-66. PubMed ID: 1383121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of differentiation antigens in mammary and extramammary Paget's disease.
    Kariniemi AL; Forsman L; Wahlström T; Vesterinen E; Andersson L
    Br J Dermatol; 1984 Feb; 110(2):203-10. PubMed ID: 6320859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of carcinoembryonic antigen in infiltrating duct carcinomas of the breast: correlation with morphofunctional parameters and prognostic significance.
    d'Amore ES; Gloghini A; Margallo E; Margiocco M; Nicoló G
    Arch Anat Cytol Pathol; 1986; 34(2):89-94. PubMed ID: 3022656
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF
    Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    Kassardjian A; Shintaku PI; Moatamed NA
    PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.